Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Adverse Cardiovascular Events (MACE)”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Post-approval studies (Phase 4)Study completedNCT01431495
What this trial is testing

Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)

Who this might be right for
Coronary Disease
Les Laboratoires des Médicaments Stériles 219
Not applicableLooking for participantsNCT07374263
What this trial is testing

Do QT-Prolonging Drugs Cause Major Adverse Cardiac Events in Hospitalized Adults?

Who this might be right for
Acquired Long QTVentricular ArrhythmiasTorsades de Pointes+3 more
St. Joseph's Healthcare Hamilton 990,000
Not applicableUnknownNCT06318767
What this trial is testing

Predictive Value of Systolic Rise Time of the Plantar Arch on the Risk of Major Adverse Limb Events (MALE) and Major Adverse Cardiovascular Events (MACE) in Peripheral Artery Disease (PAD) at Critical Ischaemia Stage

Who this might be right for
Major Adverse Limb EventsMajor Adverse Cardiovascular EventsPeripheral Artery Disease+2 more
Centre Hospitalier Universitaire, Amiens 134
Not applicableNot Yet RecruitingNCT07441759
What this trial is testing

ThroMboembolic Risk Associated To High atrIal Fibrillation riSk

Who this might be right for
MACEAtrial Fibrillation (AF)Quality-adjusted Life-years+6 more
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 1,000
Large-scale testing (Phase 3)Study completedNCT01000727
What this trial is testing

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial

Who this might be right for
Acute Coronary Syndrome
GlaxoSmithKline 13,026
Post-approval studies (Phase 4)UnknownNCT03965195
What this trial is testing

Recombinant Influenza Vaccination in U.S. Nursing Homes

Who this might be right for
InfluenzaInfluenza -Like IllnessInfluenza, Human
Insight Therapeutics, LLC 1,989
Testing effectiveness (Phase 2)Study completedNCT01103440
What this trial is testing

Aspirin Resistance and Percutaneous Coronary Intervention (PCI)

Who this might be right for
Stable Angina
Icahn School of Medicine at Mount Sinai 36
Large-scale testing (Phase 3)Study completedNCT00799903
What this trial is testing

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

Who this might be right for
Atherosclerosis
GlaxoSmithKline 15,828
Not applicableWithdrawnNCT04139655
What this trial is testing

Colchicine Prevents Myocardial Injury After Non-Cardiac Surgery Pilot Study

Who this might be right for
Myocardial InfarctionMyocardial InjuryMajor Adverse Cardiac Events+1 more
University of British Columbia
Not applicableStudy completedNCT02533128
What this trial is testing

Biomarkers, Blood Pressure, BIS: Risk Stratification/Management of Patients at Cardiac Risk in Major Noncardiac Surgery

Who this might be right for
HypotensionPostoperative ComplicationsAcute Coronary Syndrome+6 more
Miodrag Filipovic, Prof. Dr. med. 458
Not applicableLooking for participantsNCT06843005
What this trial is testing

Serial Coronary CTA-based Plaque Progression Detection for Management of Coronary Heart Disease

Who this might be right for
Major Adverse Cardiovascular Events (MACE)PreventionCoronary Artery Disease(CAD)+1 more
Zhang longjiang,MD 3,100
Not applicableStudy completedNCT02317445
What this trial is testing

Relationship of Helicobacter Pylori Eradication Therapy and Long-term Outcome in Acute Coronary Syndrome

Who this might be right for
Acute Coronary Syndrome
Capital Medical University 472
Not applicableEnded earlyNCT01173939
What this trial is testing

Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments

Who this might be right for
HypercholesterolemiaType 2 DiabetesHypertension
Positive Trial Group 10,000
Not applicableEnrolling By InvitationNCT07480629
What this trial is testing

The 10-Year Extended Follow-up of the DACAB Trial

Who this might be right for
Coronary Artery DiseaseCABGAntiplatelet Therapy of Coronary Artery Bypass
Ruijin Hospital 500
Post-approval studies (Phase 4)Study completedNCT02019264
What this trial is testing

Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors

Who this might be right for
Cardiovascular DiseaseHigh Cardiovascular RiskObesity+2 more
Eisai Inc. 14,673
Post-approval studies (Phase 4)Study completedNCT03518034
What this trial is testing

Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men

Who this might be right for
HypogonadismCardiovascular Diseases
AbbVie 5,246
Not applicableStudy completedNCT01707459
What this trial is testing

The Association Between Platelet Inhibition and Perioperative Major Adverse Cardiac Events In Post-Percutaneous Coronary Intervention (PCI) Patients Undergoing Non-Cardiac Surgery

Who this might be right for
Thrombosis
University Health Network, Toronto 201
Not applicableLooking for participantsNCT06951867
What this trial is testing

Tezspire Cardiac Events PASS

Who this might be right for
Cardiovascular EventsMACE
AstraZeneca 16,640
Not applicableNot Yet RecruitingNCT06816238
What this trial is testing

Smart Education for MACE Prevention and Early Detection

Who this might be right for
High-Risk Stroke Population
Second Affiliated Hospital, School of Medicine, Zhejiang University 87,376
Large-scale testing (Phase 3)Study completedNCT02586155
What this trial is testing

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD

Who this might be right for
Diabetes Mellitus, Type 2Coronary Artery Disease
Resverlogix Corp 2,425
Load More Results